Agreed. Hard to believe worldwide insulin sales will more than double in only four years even with very high growth in emerging markets.
do you mean a doubling isn't enough. If one of the attributes of this process is reducing the cost of production wouldn't that make it the insulin of choice in India and China
Market Data 
Markets 
AI
